Effects of nitric oxide-related compounds in the acute ketamine animal model of schizophrenia
Ludmyla Kandratavicius(Universidade de São Paulo), Jaime E. C. Hallak(Conselho Nacional de Desenvolvimento Científico e Tecnológico), Paulo Roberto Barbosa Évora(Universidade de São Paulo), Priscila Alves Balista(Centro Universitário das Faculdades Metropolitanas Unidas), Daniele C. Wolf(Universidade de São Paulo), João Pereira Leite(Universidade de São Paulo), Francisco Silveira Guimarães(Universidade de São Paulo), Cristiano Chaves(Queen's University), Alfredo José Rodrigues, Glen B. Baker(University of Alberta), João Paulo Maia‐de‐Oliveira(Universidade Federal do Rio Grande do Norte), Serdar Dursun(Centre for Addiction and Mental Health), João Abrão(Clinics Hospital of Ribeirão Preto)
Cited by 40
Related Papers
Treatment-Resistant Schizophrenia: Treatment Response and Resistance in Psychosis (TRRIP) Working Group Consensus Guidelines on Diagnosis and Terminology
|American Journal of Psychiatry|2016|1.1k
Rapid antidepressant effects of the psychedelic ayahuasca in treatment-resistant depression: a randomized placebo-controlled trial
|Psychological Medicine|2018|819
Cannabidiol Reduces the Anxiety Induced by Simulated Public Speaking in Treatment-Naïve Social Phobia Patients
|Neuropsychopharmacology|2011|763
Neural basis of anxiolytic effects of cannabidiol (CBD) in generalized social anxiety disorder: a preliminary report
|Journal of Psychopharmacology|2010|530
Antidepressant effects of a single dose of ayahuasca in patients with recurrent depression: a preliminary report
|Brazilian Journal of Psychiatry|2015|484